著者
山本 美智子
出版者
公益社団法人 日本薬学会
雑誌
YAKUGAKU ZASSHI (ISSN:00316903)
巻号頁・発行日
vol.134, no.3, pp.355-362, 2014 (Released:2014-03-01)
参考文献数
22
被引用文献数
1 3

It is necessary to offer the proper information about prescription drugs for appropriate use of them in clinical practice. However, a lot of time and labor is required to comprehensively collect the information necessary for clinical application and it could be extremely difficult. If the clinical experience and other information is derived solely on a commercial basis, then it may lead to improper prescription practices. “Academic detailing” is a form of interactive educational outreach to physicians to provide unbiased, non-commercial, evidence-based information about medications and other therapeutic decisions, with the goal of improving patient care. In Western countries, the public funds are used to support universities and other research institution programs. The experience from such programs spreads to a broader scientific community. In US, “Academic detailing” was pioneered 30 years ago. National Resource Center for Academic Detailing (NaRCAD) is an initiative supported by Agency for Healthcare Research and Quality (AHRQ) grant. Clinical pharmacists are acting as Detailers in Europe and America, and this improves medical quality. The importance of Academic Detailing activity would be also recognized in Japan, and fully-trained (with six-years of specialized training) pharmacists with evaluative and communication skills can be expected to act as such a specialist.
著者
山本 美智子 中山 健夫
出版者
日本薬学図書館協議会
雑誌
薬学図書館 (ISSN:03862062)
巻号頁・発行日
vol.53, no.3, pp.190-202, 2008-07-31 (Released:2011-09-21)
参考文献数
38
被引用文献数
2

医薬品の副作用自発報告はシグナル検出の重要な手段である。欧米数力国では患者から行政への直接副作用報告がすでに始まっている。患者からの報告は, 医師からの報告が減少する中, 増加傾向にあり, 患者はファーマコビジランスの中心的役割を演じる存在として注目されている。患者は情報を知る立場であると同時に自らの情報を発信する役割も担いつつある。今回, 患者と副作用, その報告制度について, 経緯, 現状を紹介すると共に, その意義や課題についても考察する。
著者
山本 美智子
出版者
東京女子大学
雑誌
日本文學 (ISSN:03863336)
巻号頁・発行日
vol.40, pp.55-74, 1973-11-30
著者
山本 美智子 松田 勉 須賀 万智 古川 綾 五十嵐 崇子 林 雅彦 杉森 裕樹
出版者
日本社会薬学会
雑誌
社会薬学 (ISSN:09110585)
巻号頁・発行日
vol.32, no.2, pp.8-17, 2013-12-10 (Released:2015-06-26)
参考文献数
12

The Medication Guides for Patients (MGPs) are being offered as information on prescription drugs for patients by the Ministry of Health, Labour and Welfare (MHLW). The MHLW published the Risk Management Plan in April, 2012, and it noted that the MGPs should be utilized in usual risk minimization activities. It is not clear, however, whether the MGPs are efficiently utilized in actual settings. Hence, we conducted a questionnaire survey of the pharmacists in the pharmacies with dispensing and the hospitals in Mie and Yamagata prefectures to investigate the actual circumstances of MGPs utilization and to understand the existing barriers associated with the use of the MGPs as medication instructions for patients. We sent the questionnaires by mail and obtained responses from 444 facilities (33.9%) of 1,309 facilities. The recognition level of the MGPs was about 30 percent in the dispensing pharmacies, and about 50 percent in the hospitals. The MGPs were utilized as a common communication tool with the patients in approximately 20 percent of the facilities. Many respondents requested that the frequency of important and other adverse reactions should be described in the MGPs, and wider ranges of MGPs should be further implemented.Moreover, our data suggests the problem is that the present MGPs are mainly applied to special types of patients, such as those with higher literacy level or those who requested a detailed explanation. Thus, it is apparent that it is necessary to review the MGPs contents again to improve their practical benefits and disseminate them more widely.